{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:00:54Z","timestamp":1785186054671,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":604,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacepopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACEP Open"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1002\/emp2.12813","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T02:30:12Z","timestamp":1664245812000},"page":"e12813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["4\u2010Fluoroamphetamine (4\u2010FA) intoxication results in exaggerated blood pressure effects compared to MDMA and amphetamine: A retrospective analysis"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6428-8600","authenticated-orcid":false,"given":"Femke M.J.","family":"Gresnigt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Snik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.F.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost W.","family":"Vanhommerig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan W.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Riezebos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/emp2.12813_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.drugalcdep.2015.10.011","article-title":"Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C\u2010B, 4\u2010fluoroamphetamine and benzofurans","volume":"157","author":"Nugteren\u2010van Lonkhuyzen","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/emp2.12813_bb0015","unstructured":"4\u2010Fluoroamphetamine (4\u2010FA) Critical Review Report, World Health Organization, Expert Committee on Drug Dependence, Thirty\u2010seventh Meeting, Geneva, 16\u201320 November 2015. https:\/\/researchonline.ljmu.ac.uk\/id\/eprint\/7380\/1\/WHO_2017_CR_4.3_4\u2010FA_Critical_Review.pdf"},{"issue":"2","key":"10.1002\/emp2.12813_bb0020","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1124\/jpet.104.080101","article-title":"Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs","volume":"313","author":"Wee","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1002\/emp2.12813_bb0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.110.176271","article-title":"In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat","volume":"337","author":"Baumann","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1002\/emp2.12813_bb0030","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00204-012-0815-5","article-title":"Toxicity of amphetamines: an update","volume":"86","author":"Carvalho","year":"2012","journal-title":"Arch Toxicol"},{"key":"10.1002\/emp2.12813_bb0035","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.toxrep.2020.12.003","article-title":"Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4\u2010Fluoroamphetamine in a healthy young individual","volume":"7","author":"van der Pas","year":"2020","journal-title":"Toxicol Reports"},{"issue":"2015","key":"10.1002\/emp2.12813_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","article-title":"Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre","volume":"147","author":"Hondebrink","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/emp2.12813_bb0045","series-title":"European Drug Report 2019: Trends and Developments. Publications Office of the European Union","year":"2019"},{"key":"10.1002\/emp2.12813_bb0050","series-title":"Het Grote Uitgaansonderzoek, Uitgaanspatronen, middelengebruik en risicogedrag onder uitgaande jongeren en jongvolwassenen","author":"Goossens","year":"2013"},{"key":"10.1002\/emp2.12813_bb0055","series-title":"Het Grote Uitgaansonderzoek, Uitgaanspatronen, middelengebruik en preventieve maatregelen onder uitgaande jongeren en jongvolwassenen","author":"Monshouwer","year":"2016"},{"issue":"1\u20133","key":"10.1002\/emp2.12813_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.forsciint.2011.04.004","article-title":"Detection of the synthetic drug 4\u2010fluoroamphetamine (4\u2010FA) in serum and urine","volume":"215","author":"R\u00f6hrich","year":"2012","journal-title":"Forensic Sci Int"},{"issue":"4","key":"10.1002\/emp2.12813_bb0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00414-012-0671-0","article-title":"Isomers of fluoroamphetamines detected in forensic cases in Denmark","volume":"126","author":"Johansen","year":"2012","journal-title":"Int J Legal Med"},{"issue":"5","key":"10.1002\/emp2.12813_bb0070","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00414-015-1150-1","article-title":"Driving under the influence of synthetic phenethylamines: a case series","volume":"129","author":"Maas","year":"2015","journal-title":"Int J Legal Med"},{"issue":"3","key":"10.1002\/emp2.12813_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/15563650.2015.1009994","article-title":"Ice water submersion for rapid cooling in severe drug\u2010induced hyperthermia","volume":"53","author":"Laskowski","year":"2015","journal-title":"Clin Toxicol"},{"issue":"10","key":"10.1002\/emp2.12813_bb0080","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3109\/15563650.2014.974262","article-title":"Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels","volume":"52","author":"Al\u2010Abri","year":"2014","journal-title":"Clin Toxicol"},{"issue":"4","key":"10.1002\/emp2.12813_bb0085","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/dta.1988","article-title":"Acute dilated cardiomyopathy and myocardial injury after combined 4\u2010fluoroamphetamine and modafinil ingestion","volume":"9","author":"Wolf","year":"2017","journal-title":"Drug Test Anal"},{"issue":"7\u20138","key":"10.1002\/emp2.12813_bb0090","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/dta.1610","article-title":"New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?","volume":"6","author":"Gin\u00e9","year":"2014","journal-title":"Drug Test Anal"},{"key":"10.1002\/emp2.12813_bb0095","volume":"13","year":"2020"},{"key":"10.1002\/emp2.12813_bb0100","volume":"1","author":"Van Laar","year":"2019"},{"issue":"7","key":"10.1002\/emp2.12813_bb0105","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/add.12932","article-title":"4\u2010Fluoroamphetamine in the Netherlands: more than a one\u2010night stand","volume":"110","author":"Linsen","year":"2015","journal-title":"Addiction"},{"key":"10.1002\/emp2.12813_bb0110","unstructured":"van der Gouwe D, Rigter S. Annual Report 2015, Drugs Information and Monitoring System (DIMS). Utrecht; 2016. https:\/\/www.trimbos.nl\/wp-content\/uploads\/sites\/31\/2021\/09\/inf012-annual-report-2015.pdf"},{"issue":"3","key":"10.1002\/emp2.12813_bb0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.annemergmed.2017.07.482","article-title":"Fatalities, cerebral hemorrhage, and severe cardiovascular toxicity after exposure to the new psychoactive substance 4\u2010fluoroamphetamine: a prospective Cohort study","volume":"71","author":"Hondebrink","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"7","key":"10.1002\/emp2.12813_bb0120","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00415-018-8888-6","article-title":"Haemorrhagic stroke related to the use of 4\u2010fluoroamphetamine","volume":"265","author":"Wijers","year":"2018","journal-title":"J Neurol"},{"key":"10.1002\/emp2.12813_bb0125","article-title":"\u201cEcstasy\u2010light\u201d: niet zo onschuldig als het lijkt: toxische effecten van 4\u2010fluoramfetamine","volume":"16","author":"Knippels","year":"2017","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"2","key":"10.1002\/emp2.12813_bb0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jat\/bkv139","article-title":"4\u2010fluoroamphetamine in serum and urine from an intoxicated patient with life\u2010threatening hyperpyrexia","volume":"40","author":"Poklis","year":"2016","journal-title":"J Anal Toxicol"},{"key":"10.1002\/emp2.12813_bb0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.toxrep.2020.04.007","article-title":"Toxicological screening in the Amsterdam acute setting becomes more relevant if the standard panel of the drugs\u2010of\u2010abuse point\u2010of\u2010care test is expanded with GHB and ketamine","volume":"7","author":"van der Schaar","year":"2020","journal-title":"Toxicol Rep"},{"issue":"1","key":"10.1002\/emp2.12813_bb0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/FTD.0000000000000475","article-title":"Lack of detection of new amphetamine\u2010like drugs using conventional urinary immunoassays","volume":"40","author":"Begeman","year":"2018","journal-title":"Ther Drug Monit"},{"issue":"3","key":"10.1002\/emp2.12813_bb0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/15563659809028940","article-title":"Poisoning severity score. Grading of acute poisoning","volume":"36","author":"Persson","year":"1998","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1002\/emp2.12813_bb0150","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Hear J"},{"issue":"2","key":"10.1002\/emp2.12813_bb0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST\u2010segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST\u2010segment elevation of the European Society","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1002\/emp2.12813_bb0160","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST\u2010segment elevation The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST\u2010segment elevation o","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1002\/emp2.12813_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ehjcvp\/pvy032","article-title":"ESC Council on hypertension position document on the management of hypertensive emergencies","volume":"5","author":"van den Born","year":"2019","journal-title":"Eur Hear J \u2010 Cardiovasc Pharmacother"},{"issue":"7","key":"10.1002\/emp2.12813_bb0170","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"key":"10.1002\/emp2.12813_bb0175","series-title":"4\u2010Fluoramfetamine: Gebruikers en Gebruik in Beeld","author":"Van Der Pol","year":"2017"},{"issue":"5","key":"10.1002\/emp2.12813_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11916-019-0767-z","article-title":"The hypertensive headache: a review","volume":"23","author":"Arca","year":"2019","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"10.1002\/emp2.12813_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The international classification of headache disorders, 3rd ed","volume":"38","year":"2018","journal-title":"Cephalalgia an Int J Headache"},{"key":"10.1002\/emp2.12813_bb0190","unstructured":"van der Gouwe D, Vrolijk R. Annual Report 2018, Drugs Information and Monitoring System (DIMS). Utrecht; 2019. https:\/\/www.trimbos.nl\/wp-content\/uploads\/sites\/31\/2021\/09\/inf037-dims-annual-report-2018.pdf"},{"key":"10.1002\/emp2.12813_bb0195","unstructured":"Vrolijk R, van der Gouwe D. Annual Report 2019, Drugs Information and Monitoring System (DIMS). Utrecht; 2020. https:\/\/www.trimbos.nl\/wp-content\/uploads\/sites\/31\/2021\/09\/inf102-dims-annual-report-2019.pdf"},{"issue":"4","key":"10.1002\/emp2.12813_bb0200","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/002204260403400412","article-title":"What if we're wrong? Some possible implications of systematic distortions in adolescents\u2019 self\u2010reports of sensitive behaviors","volume":"34","author":"Johnson","year":"2004","journal-title":"J Drug Issues"},{"issue":"4","key":"10.1002\/emp2.12813_bb0205","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1360-0443.2011.03473.x","article-title":"Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end\u2010points in clinical trials","volume":"107","author":"Donovan","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/emp2.12813_bb0210","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3343\/alm.2017.37.6.522","article-title":"Evaluation of the triage TOX drug screen assay for detectiondetection of 11 drugsdrugs of abuseabuse and therapeutic drugstherapeutic drugs","volume":"37","author":"Bang","year":"2017","journal-title":"Ann LanLab Med"}],"container-title":["JACEP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/emp2.12813","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/emp2.12813","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115224002509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115224002509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/emp2.12813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:45:58Z","timestamp":1737737158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2688115224002509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2688115224002509"],"URL":"https:\/\/doi.org\/10.1002\/emp2.12813","relation":{},"ISSN":["2688-1152"],"issn-type":[{"value":"2688-1152","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4\u2010Fluoroamphetamine (4\u2010FA) intoxication results in exaggerated blood pressure effects compared to MDMA and amphetamine: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"JACEP Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/emp2.12813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"e12813"}}